Fig. 2.
Ga68-PSMA PET-CT maximum intensity projection pre (a) and 8 weeks post (b) Lu-177-PSMA therapy images showed stable disease. This 68 years old prostate cancer patient earlier treated with bilateral orchidectomy, multiple lines of anti-androgens including abiraterone, enzalutamide and two lines of chemotherapy docetaxel and cabazitaxel. Pre and 8 weeks post Lu-177-PSMA therapy, PSA showed stable disease (396.6 ng/ml vs 344 ng/ml)
